Complete relief of pain in acute painful diabetic neuropathy of rapid glycaemic control (insulin neuritis) with venlafaxine HCL

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 17, Issue 4, 2004, Pages 247-249

  Guldiken, Sibel ^a,c   Guldiken, B ^b   Arikan, E ^a   Altun Ugur, B ^a   Kara, M ^a   Tugrul, A ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b Social Security Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Acute painful diabetic neuropathy; Insulin treatment; Type 2 diabetes mellitus; Venlafaxine HCL

Indexed keywords

ACARBOSE; GABAPENTIN; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; VENLAFAXINE;

ADULT; ALCOHOLISM; ANALGESIA; ANXIETY DISORDER; ARTICLE; BURNING SENSATION; CASE REPORT; CYANOCOBALAMIN DEFICIENCY; DAILY LIFE ACTIVITY; DEPRESSION; DIABETIC DIET; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FOLIC ACID DEFICIENCY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPESTHESIA; LEG PAIN; MALE; NEUROPATHIC PAIN; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN ASSESSMENT; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; UREMIA; VISUAL ANALOG SCALE;

ACUTE DISEASE; ANALGESICS; BLOOD GLUCOSE; CYCLOHEXANOLS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HUMANS; MALE; MIDDLE AGED; PAIN; TREATMENT OUTCOME;

EID: 8644291754     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pirart J.: Diabetes mellitus and its degenerative complications: a prospective study of 4.400 patients observed between 1947 and 1973. Diabetes Care 1: 168-252, 1978.
2. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., Wilson D.M., O'Brien P.C., Melton L.J. 3rd, Service F.J.: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993.
3. Amos A.F., McCarty D.J., Zimmet P.: The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet. Med. 14: S7-S85, 1997.
4. Quattrini C., Tesfaye S.: Understanding the impact of painful diabetic neuropathy. Diabetes Metab. Res. Rev. 19: S2-S8, 2003.
5. Chapman C.R., Casey K.L., Dubner R., Foley K.M., Gracely R.H., Reading A.E.: Pain measurement, an overview. Pain 22: 1-31, 1985.
6. Green D.A., Lattimer S.A., Sima A.A.: Pathogenesis and prevention of diabetic, neuropathy. Diabetes Metab. Rev. 4: 201-221, 1988.
7. Winegrad A.I.: Does a common mechanism induce the diverse complications of diabetes? Banting Lecture 1986. Diabetes 36: 396-406, 1987.
8. Archer A.G., Watkins P.J., Thomas P.J., Sharma A.K., Payan J.: The natural history of acute painful neuropathy in diabetes mellitus. J. Neurol. Neurosurg. Psychiatry 46: 491-496, 1983.
9. Singleton J.R., Smith A.G., Bromberg M.B.: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24: 1225-1228, 2001.
10. Tesfaye S., Malik R., Harris N., Jakubowski JJ., Mody C., Rennie I.G., Ward J.D.: Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 39: 329-335, 1996.
11. Kihara M., Zollman P.J., Smithson I.L., Lagerlund T.D., Low P.A.: Hypoxic effect of endogenous insulin on normal and diabetic peripheral nerve. Am. J. Physiol. 266: E980-E985, 1994.
12. Handelsman D.J., Turtle J.R.: Clinical trial of an aldose reductase inhibitor in diabetic neuropathy. Diabetes 30: 459-464, 1981.
13. Oskarsson P., Ljunggren J., Lins P.: Efficacy and safety to mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group. Diabetes Care 20: 1594-1597, 1997.
14. Zhang W.Y., Li Wa Po A.: The effectiveness of topically applied capsaicin. A meta-analysis. Eur. J. Clin. Pharmacol. 46: 517-522, 1994.
15. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., Garofalo E.: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diyabetes mellitus: a randomized controlled trial. J.A.M.A. 280: 1831-1836, 1998.
16. Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., Dubner R.: Effects of desipramine, amitriptyline, and fluoxetine on pain in diyabetic neuropathy. N. Engl. J. Med. 326: 1250-1256, 1992.
17. Rull J.A., Quibrera R., Gonzales-Millam H., Castaneda L.O.: Symptomatic treatment of peripheral neuropathy with carbamazepine (Tegretol): double-blind cross-over trial. Diabetologia 5: 215-218, 1969.
18. Davis J.L., Smith R.L.: Painful peripheral diabetic neuropathy treated with venlafaxine HLC extended release capsules. Diabetes Care 22: 1909-1910, 1999.
19. Lithner F.: Venlafaxine in treatment of severe painful diabetic neuropathy. Diabetes Care 23: 1710-1711, 2000.
20. Kiayias J.A., Vlachou E.D., Laka-Papadodima E.: Venlafaxine HCL in the treatment of painful peripheral diabetic neuropathy. Diabetes Care 23: 699, 2000.
21. Morton W.A., Sonne S.C., Verga M.A.: Venlafaxine: a structurally unique and novel antidepressant. Ann. Pharmacother 29: 387-395, 1995.
22. Rudolph R.L., Derivan A.T.: The safety and tolerability of venlafaxine HCL: analysis of the clinical trials database. J. Clin. Psychopharmacol. 16: 54-59, 1996.
23. Goodnick P.J.: Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann. Clin. Psychiatry 13: 31-41, 2001.
24. Wolfe G.I., Barohn R.J.: Painful peripheral neuropathy. Curr. Treat. Options Neurol. 4: 177-188, 2002.